Option chain shows key data for General Copper Gold's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for General Copper Gold.

General Copper Gold (OTC:GNRGF) Stock, Option Chain

General Copper Gold Corp is an independent mineral exploration company. It is engaged in the business of exploring and evaluating mineral properties. The company is exploring 770 hectares of Clark's Brook gold property in central Newfoundland as well as hectares of Topley Richfield copper-gold property in British Columbia.

GENERAL COPPER GOLD CORP by General Copper Gold Corp.

General Copper Gold Corp

News

JP Morgan CEO Jamie Dimon Says We Have 450 Use Cases For AI Now, It Could Go Up To 1,000 Use Cases By Next Year

Canadian Natural Res (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNQ#NYSE">CNQ</a>) has outperformed the market over the past 5 years by 3.51% on an annualized basis producing an average annual return of 17.93%. Currently, Canadian Natural Res has a market capitalization of $59.34 billion. 
Buying $100 In CNQ: If an investor had bought $100 of CNQ stock 5 years ago, it would be worth $220.32 today based on a price of $28.08 for CNQ at the time of writing.
<h3>Canadian Natural Res's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740774652_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $100 Invested In Canadian Natural Res 5 Years Ago Would Be Worth Today

Entergy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETR#NYSE">ETR</a>) short percent of float has fallen 7.96% since its last report. The company recently reported that it has 6.98 million shares sold short, which is 1.85% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.43 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Entergy Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740774635_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Entergy has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Entergy's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Entergy's peer group average for short interest as a percentage of float is 2.41%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

What Does the Market Think About Entergy?

Ally Financial's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>) short percent of float has risen 27.35% since its last report. The company recently reported that it has 8.69 million shares sold short, which is 2.84% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.85 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Ally Financial Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740774630_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Ally Financial has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Ally Financial's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Ally Financial's peer group average for short interest as a percentage of float is 6.90%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

ALLY

What Does the Market Think About Ally Financial?

Insulet's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PODD#NYSE">PODD</a>) short percent of float has fallen 11.61% since its last report. The company recently reported that it has 2.16 million shares sold short, which is 4.11% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.58 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Insulet Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740774625_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Insulet has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Insulet's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Insulet's peer group average for short interest as a percentage of float is 3.97%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

PODD

What's Driving the Market Sentiment Around Insulet?

Most people know that <a href="https://www.benzinga.com/startups/25/01/42802794/there-wont-be-money-for-social-security-elon-musk-tells-joe-rogan-about-looming-bankruptcy-and-1-1-trillion-interest">Social Security</a> alone won't be enough for a comfortable retirement. The numbers don't lie—the average monthly benefit in 2025 is around $1,976, adding up to about $23,712 a year, according to<a href="https://www.ssa.gov/faqs/en/questions/KA-01903.html?utm_source=chatgpt.com"> the Social Security Administration</a>.&nbsp;
That's why so many Americans rely on personal savings, 401(k)s, and IRAs to bridge the gap. But there's still a big debate about how Social Security should work and how people should be investing for their future.
Don't Miss:
<ul>
<li>The average 401(k) balance soars to a record-breaking high – <a href="https://www.benzinga.com/money/average-401k-balances-soars-to-record-high">Here's how to know if your nest egg is keeping pace.</a></li>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
</ul>
<h2 class="wp-block-heading">Should Social Security Be Means-Tested, and How Should You Invest?</h2>
<a href="https://www.troweprice.com/personal-investing/resources/insights/how-to-determine-amount-of-income-you-will-need-at-retirement.html">According to T. Rowe Price</a>, a widely accepted guideline is to aim for a retirement income that replaces approximately 75% of your pre-retirement salary.&nbsp;
That's why employer-sponsored 401(k) plans and IRAs have become such an important part of retirement planning—they help people grow their savings and take control of their financial future.
But the way Social Security benefits are handed out has become a hot topic, and some experts think it's time for a change.
Trending: ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a>
Scott Galloway, an NYU professor and host of "The Prof G Pod" podcast, believes Social Security should be means-tested—meaning wealthier individuals shouldn't receive benefits just because they paid in. He argues that he pays the same amount in Social Security taxes as someone making $160,000 a year.&nbsp;
"So I have analysts working here at ProfG who make 160 grand. So they make, or they pay $9,000 in social security tax. I make 16 million and I pay $9,000. Why on earth are the rich not paying their share to support our seniors? So if you&#8217;re going to continue to transfer this much money to seniors and you think it&#8217;s a good idea, fine," Galloway said.
His take? Social Security is a tax meant to support those who need it, and high earners like himself don't necessarily need the extra money.
Not everyone agrees. According to<a href="https://www.cbpp.org/research/social-security/means-testing-social-security-the-challenges-ahead"> the Center on Budget and Policy Priorities</a>, means-testing could actually weaken Social Security. One of the program's biggest strengths is that it's universal—everyone pays in, and everyone gets something back.&nbsp;
If benefits get cut for high earners, Social Security might start looking like a welfare program, making it an easier target for budget cuts down the line.
See Also: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
Beyond Social Security, Galloway has strong opinions on <a href="https://www.benzinga.com/startups/25/01/43416787/the-5-million-lunch-that-changed-it-all-how-ted-weschler-met-warren-buffett-and-built-a-269-million-retirement-account">retirement</a> investing. In his book, "The Algebra of Wealth," he warns that putting too much money into risky investments—like growth stocks and derivatives—can be a huge mistake.&nbsp;
"Diversification is the kevlar that protects you—with it, bad decisions will still hurt, but they won't prove fatal," he said, arguing that if all your savings are in just a few risky assets, a bad bet could wipe you out. He stresses that the goal isn't to chase the biggest returns—it's to build long-term security.
Still, some experts think a little risk is necessary. <a href="https://investor.vanguard.com/investor-resources-education/education/model-portfolio-allocation">Per Vanguard</a>, a well-balanced mix of stocks and bonds tends to generate the best long-term returns, and having some exposure to growth stocks can actually boost wealth over time.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/millionaires-never-earned-six-figures-according-to-dave-ramsey">69% of Millionaires Never Earned A Six-Figure Salary – Here Are 2 Things They Do To Get Their First $1 Million, According To Dave Ramsey</a></li>
<li>Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
</ul>

Personal Finance

Scott Galloway Urges 'Means-Testing' For Social Security – 'I Make $16M A Year, I Shouldn't Get A Check'

Many of the top-performing stocks and assets in recent years have stumbled at the start of 2025, with Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) dropping to <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43987636/bitcoin-tumbles-below-85000-amid-president-trumps-eu-tariff-threats">a three-month low.</a>
Here's a look at the year-to-date performance of top 2024 assets and what's outperforming them.
What Happened: Bitcoin was a top performer in 2024, rising over 100% and hitting multiple all-time highs throughout the year, including shortly after Donald Trump won the 2024 presidency.
While Bitcoin rebounded in January, the leading cryptocurrency has since reversed course, down 10.4% year-to-date in 2025. Once seen as a hedge against interest rates, inflation, and macroeconomic concerns, Bitcoin is now declining alongside other traditionally perceived safe-haven assets.
Magnificent Seven stocks, which were also top performers in recent years, have also been underperformers in 2025, compared to the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>). Here are the year-to-date returns.
<ul>
<li>Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>): -2.4%</li>
<li>Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>): -5.3%</li>
<li>Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>): -10.4%</li>
<li>Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>): +9.9%</li>
<li>Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>): -6.4%</li>
<li>NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>): -12.8%</li>
<li>Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>): -24.5%</li>
</ul>
Compare that to the SPY, which is trading nearly even with its starting year price with a current share price of $585.03. At the time of writing, the ETF is up 39 cents on the year, or 0.07%.
Technology stocks have also outperformed in recent years, helping boost the investment returns of the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>). The ETF, which is heavily weighted in tech stocks, is down 2.0% year-to-date in 2025.
Read Also: <a href="https://www.benzinga.com/trading-ideas/technicals/25/02/44043021/tesla-the-only-magnificent-seven-stock-in-freefall-can-it-reverse-course">Tesla: The Only Magnificent Seven Stock In Freefall &#8211; Can It Reverse Course?</a>
The Outperformers: While Bitcoin, tech and the Magnificent Seven stocks are down year-to-date in 2025, there are several places that are outperforming the broad market.
One of the top places is the Dow Jones Industrial Average, tracked by the SPDR Dow Jones Industrial Average ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>). The ETF is up 2.1% year-to-date in 2025, outperforming the SPY and QQQ. This often happens during periods of economic uncertainty or when industrial and manufacturing investments are stronger than technology investments.
Of the 30 Dow Jones Industrial Average stocks, 19 are positive year-to-date in 2025—a sharp contrast to the Magnificent Seven, where only one of seven stocks is in the green this year.
Among the Dow Jones Industrial Average stocks, these are the top gainers year-to-date that are each up by double digits:
<ul>
<li>Amgen Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>): +17.5%</li>
<li>International Business Machines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>): +16.4%</li>
<li>3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>): +14.2%</li>
<li>Coca-Cola (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>): +13.7%</li>
<li>Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>): +12.8%</li>
<li>Visa Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>): +10.9%</li>
</ul>
Berkshire Hathaway Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>, NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) shares are up 12.3% year-to-date in 2025, despite struggles from its top portfolio holding, Apple. The Warren Buffett-led conglomerate has a history of outperforming the S&amp;P 500, and 2025 could be another strong year.
Perhaps among the bigger surprises for outperformers in 2025 are Chinese stocks. Using <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022825&amp;t=be2bearmibe3na1">the Benzinga Pro </a>screener tool and looking for the top performing stocks year-to-date with market capitalizations of $1 billion or more revealed Xpeng Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) and Alibaba Group Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) among the top performers up 82% and 57% respectively.
Chinese ETFs are also performing well in 2025, here are the returns of some of the largest:
<ul>
<li>KraneShares CSI China Internet ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KWEB#NYSE">KWEB</a>): +17.4%</li>
<li>iShares China Larce-Cap ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXI#NYSE">FXI</a>): +17.2%</li>
<li>iShares MSCI China ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHI#NASDAQ">MCHI</a>): +15.9%</li>
</ul>
The strong returns of several Chinese stocks and the ETFs come as the country faces<a href="https://www.benzinga.com/news/global/25/02/44010093/trumps-plan-for-canada-mexico-china-tariffs-to-start-march-4-could-shake-stock-market"> proposed additional tariffs</a> from President Donald Trump.
With only two months of 2025 behind us, the landscape could change significantly in the next 10 months.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/25/01/43403758/exclusive-this-magnificent-7-stock-will-feel-the-pinch-of-feds-rate-decision-poll-shows">EXCLUSIVE: This &#8216;Magnificent 7&#8217; Stock Will Feel The Pinch Of Fed&#8217;s Rate Decision, Poll Shows</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Tech

$BTC

AAPL

AMGN

AMZN

BABA

SPDR Dow Jones Industrial Average ETF Trust

GOOG

GOOGL

KWEB

MCHI

MSFT

NVDA

TSLA

XPEV

Bitcoin, Magnificent 7 Lose Safe-Haven Status In 2025 As China ETFs, Dow Stocks Outperform

WIIM

BLND

Blend Labs shares are trading lower after the company reported worse-than-expected Q4 adjusted EPS results.

Cryptocurrency markets are rebounding from an overnight dip that saw Bitcoin go <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44039431/bitcoin-plummets-below-80000-ethereum-xrp-dogecoin-get-hammered-as-crypto-crash-continues">as low as $78,300</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>&nbsp;$84,650.16</td>
<td>+1.7%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$2,233.35</td>
<td>-1.7%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>&nbsp;$146.31</td>
<td>+8.3%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>&nbsp;$2.15</td>
<td>-0.7%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.2013</td>
<td>-0.9%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00001389</td>
<td>-2.8%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows large transaction volume decreasing by 26.1%. Daily active addresses grew by 6.3%. Transactions greater than $100,000 are down from 13,305 to 12,754 in a single day. Exchanges netflows are down by 148.7%.</li>
<li>Coinglass data reports 233,253 traders were liquidated in the past 24 hours for $1.01 billion.</li>
<li>IntoTheBlock data shows Bitcoin's active addresses reached the highest daily level since December 2024. Spikes in on-chain activity coincides with market peaks and bottoms. This surge implies the market could be at a crucial turning point.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44048486/bitcoins-24-correction-mostly-technical-say-experts">Bitcoin&#8217;s 24% Correction &#8216;Mostly Technical&#8217; Say Experts</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44050992/the-real-reason-why-bitcoin-is-down-14-in-7-days-and-may-go-down-more">The Real Reason Why Bitcoin Is Down 14% In 7 Days (And May Go Down More)</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44041389/bitcoin-will-still-hit-500000-before-trump-leaves-office-standard-chartered-analyst-maintains">Bitcoin Will Still Hit $500,000 Before Trump Leaves Office, Standard Chartered Analyst Maintains</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44046215/bitvm-integration-unlocks-bitcoins-19-trillion-liquidity-across-five-major-blockchains">BitVM Integration Unlocks Bitcoin&#8217;s $1.9 Trillion Liquidity Across Five Major Blockchains</a></li>
<li><a href="https://www.benzinga.com/25/02/44032261/michael-saylor-advocates-for-us-leadership-in-bitcoin-and-crypto-to-house-financial-services-committee">Michael Saylor Presents &#8216;Digital Assets Framework&#8217; To House Committe, Pitches For US Supremacy In Bitcoin, Crypto</a></li>
</ul>
Top Gainers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Berachain (CRYPTO: BERA)</td>
<td>&nbsp;$8.41</td>
<td>+12.4%</td>
</tr>
<tr>
<td>Celsetia (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TIA</a>)</td>
<td>&nbsp;$4.05</td>
<td>+12.3%</td>
</tr>
<tr>
<td>Hedera (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/hbar/usd">HBAR</a>)</td>
<td>&nbsp;$0.2151</td>
<td>+10%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: BTC has fallen 19% over the past week, prompting trader Altcoin Sherpa to question whether a short-term recovery is possible.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Lets see if we can break this cycle of poverty in the short term for <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> <a href="https://t.co/ZWhyzAsXXz">pic.twitter.com/ZWhyzAsXXz</a>
&mdash; Altcoin Sherpa (@AltcoinSherpa) <a href="https://twitter.com/AltcoinSherpa/status/1895533795186774154?ref_src=twsrc%5Etfw">February 28, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Santiment data highlights how traders consistently misjudge BTC's direction. Mentions of $70,000-$75,000 (bearish) and $90,000-$95,000 (bullish) indicate that when traders expect BTC to rise, it falls—and vice versa.
Trader Blockchainedbb points to liquidity above $107,000, with $110,000 as the next major profit-taking zone. Meanwhile, CrediBULL Crypto sees relief after BTC tagged $79,000, expecting a base to form between $74,000 (HTF demand) and $94,000-$99,000 (local supply) before a full reversal.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">More like 2025! Liquidity above 107k ! Around 110k ish is next major profit taking <a href="https://t.co/LDM2mEVSMH">https://t.co/LDM2mEVSMH</a> <a href="https://t.co/GQeVR1xgOF">pic.twitter.com/GQeVR1xgOF</a>
&mdash; Blockchainedbb (@blockchainedbb) <a href="https://twitter.com/blockchainedbb/status/1895558550178734140?ref_src=twsrc%5Etfw">February 28, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44044388/michael-saylor-says-sell-a-kidney-but-keep-the-bitcoin-but-mstr-is-down-28-since-he-appeared-on-the-cover-of-forbes">Michael Saylor Says &#8216;Sell A Kidney, But Keep The Bitcoin&#8217;, But MSTR Is Down 28% Since He Appeared On The Cover Of Forbes</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$ETH

$HBAR

$SHIB

$SOL

$TIA

$XRP

Bitcoin, Ethereum, XRP, Dogecoin Rebound From The Brink: Here Are The Key Levels To Watch

Ukraine&#8217;s President Volodymyr Zelenskyy met with President Donald Trump and Vice President JD Vance on Friday but left the White House without signing an <a href="https://www.benzinga.com/news/global/25/02/44053592/white-house-meeting-turns-tense-as-trump-warns-zelenskyy-youre-gambling-with-world-war-iii">agreement for rare minerals</a>.
The meeting, originally set to finalize the deal over critical minerals as a form of repayment for military aid, escalated into a heated exchange as Trump accused the Ukrainian leader of<a href="https://www.benzinga.com/news/global/25/02/44053592/white-house-meeting-turns-tense-as-trump-warns-zelenskyy-youre-gambling-with-world-war-iii"> "gambling with World War III."</a>
"You're either going to make a deal or we're out," Trump noted. "And if we're out, you'll fight it out and I don't think it's going to be pretty."
Trump&#8217;s administration moved to sign the proposal earlier this month, but <a href="https://www.benzinga.com/markets/commodities/25/02/43788546/ukraine-officials-stall-trumps-colonial-rare-earths-bid-prefer-mutually-beneficial-deal">Ukrainian officials stalled</a>. They called the bid exploitative and rushed and stated that Kyiv could not accept it in that form.
After weeks of negotiation, the two parties found common ground, dropping Trump&#8217;s original $500 billion proposal but <a href="https://www.benzinga.com/25/02/43968607/trump-negotiates-a-very-big-deal-for-ukraines-mineral-wealth">not including security guarantees</a> — one of Kyiv&#8217;s key demands, which Trump wanted to address "later on." According to the Kiel Institute for the World Economy, the U.S. donated $118 billion during the three-year conflict.
Rare earth minerals are used in numerous modern technologies, from electric vehicles to defense systems. Per EU classifications, Ukraine holds deposits of 22 out of 34 of those minerals. Still, in a war-ridden country, getting to those minerals might be an issue.
According <a href="https://www.aljazeera.com/news/2025/2/28/mapping-ukraines-rare-earth-and-critical-minerals">to</a> Al Jazeera, most of those deposits are in Luhansk, Donetsk, Zaporzhizhia, Dnipropetrovsk, Korovohrad, Poltava and Kharkiv, with the Russian Federation controlling about 40% of them.
Besides the war factor, BCA Research Chief Strategist Marko Papic noted yet another issue.
"Even if you somehow manage to get the rare earths out, the question would be — where do you refine them? And the fact is that most of them would have to go to China. I mean, that&#8217;s the critical bottleneck in this whole situation," he <a href="https://www.linkedin.com/posts/marko-papic-geopolitics_does-the-rare-earth-deal-matter-im-out-activity-7301045940683997184-YB4b?">said</a> on LinkedIn.
Furthermore, Papic sees the entire situation as Trump&#8217;s way of garnering domestic support.
"I think it&#8217;s the way to effectively build domestic political consensus for continued support of Ukraine. Many of his voters, many of his supporters, many conservatives in the U.S., specifically Republican voters, are increasingly becoming skeptical of continued support for Ukraine. Polling shows that the vast majority believe that Ukraine&#8217;s aid has already been too much. Therefore, this is the way for President Trump to do something domestically," he noted, pointing at the parallels with the USMCA agreement from 2020.
"This is something that President Trump does over and over again. The theater surrounding many of his deals, the back and forth, calling countries bad names, saying they should be states of the United States &#8230; that&#8217;s in many ways designed to build domestic consensus, particularly among his voters," Papic concluded
Read Next: • <a href="https://www.benzinga.com/media/25/02/44052145/taiwan-semi-faces-geopolitical-strain-due-to-us-scrutiny-on-huaweis-chip-access">Taiwan Semi Faces Geopolitical Strain Due To US Scrutiny On Huawei&#8217;s Chip Access</a>

Commodities

Politics

Global

Markets

'This Is Something That President Trump Does Over And Over Again,' Geopolitical Strategist Says About Failed Rare Minerals Deal With Ukraine President Zelenskyy

Stablecoins are the future of commerce, according to Tom Vieira, Head of Product for Base, Coinbase's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) Layer-2 network. He highlighted on Friday their role in driving a global <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43810566/stablecoins-are-a-big-deal-but-not-where-youd-expect-bernstein-says">on-chain economy</a>.
What Happened: Speaking with Benzinga in an interview, Vieira pointed to stablecoins' utility in payments as a key example of real-world cryptocurrency adoption, alongside gaming and social applications, as Base scales to meet consumer needs with recent performance boosts.
Vieira elaborated on stablecoins' practicality within Base's ecosystem, emphasizing their potential to enable local currency transactions worldwide. 
"Stablecoins really are the future of commerce and we are passionate," he said, detailing a vision where every country could have its own stablecoin, preserving local economic preferences over dollarization.
He cited Base's "Based Around the World" tour last year—spanning Kenya, India, Thailand, Singapore, Malaysia, and the Philippines—as evidence of this push, bolstered by a testnet upgrade cutting transaction times to 200 milliseconds from two seconds, with mainnet rollout pending.
Beyond payments, Vieira highlighted gaming and social platforms as additional on-chain successes. In gaming, apps like Blocklord's Dynasty and Super Champs allow players to own and earn from digital collectibles, unlike Web2 models such as Fortnite. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44048486/bitcoins-24-correction-mostly-technical-say-experts">Bitcoin&#8217;s 24% Correction &#8216;Mostly Technical&#8217; Say Experts</a>
Socially, "Apps like Farcaster, Zora, and Rodeo are really innovating to help connect fans closer with creators so that creators earn more," he said, noting higher creator take rates compared to traditional media. 
These use cases, he argued, demonstrate adoption beyond speculation, supported by Base's focus on builder sustainability through grants and build-a-thons, including last year's $1 million ETH giveaway.
Vieira tied Base's efforts to broader Ethereum scaling, with contributions like blob space enhancements, while addressing decentralization. 
"We want to make sure that we strike the right balance of a performance sequencer that is fast, affordable block space, but that still maintains the good critical properties of blockchain," he said, referencing fault proofs launched last quarter and a 2025 stage-one decentralization goal. 
Base's smart wallet, now with sub-accounts, aims to ease onboarding, a bottleneck he sees as critical to mainstream adoption.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44046215/bitvm-integration-unlocks-bitcoins-19-trillion-liquidity-across-five-major-blockchains">BitVM Integration Unlocks Bitcoin&#8217;s $1.9 Trillion Liquidity Across Five Major Blockchains</a></li>
</ul>
Image: Shutterstock

COIN

Stablecoins Are Future Of Commerce, Says Base's Tom Vieira

Valero Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLO#NYSE">VLO</a>) has outperformed the market over the past 15 years by 1.88% on an annualized basis producing an average annual return of 13.42%. Currently, Valero Energy has a market capitalization of $40.86 billion. 
Buying $1000 In VLO: If an investor had bought $1000 of VLO stock 15 years ago, it would be worth $6,628.26 today based on a price of $129.72 for VLO at the time of writing.
<h3>Valero Energy's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740773751_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Valero Energy 15 Years Ago Would Be Worth This Much Today

In the current market session, Fidelity National Info Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIS#NYSE">FIS</a>) share price is at $70.51, after a 1.82% increase. Moreover, over the past month, the stock decreased by 13.45%, but in the past year, went up by 1.53%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1740773733_0.png" alt="Past Year Chart" />

<h3>Comparing Fidelity National Info P/E Against Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Fidelity National Info has a lower P/E than the aggregate P/E of 91.93 of the Financial Services industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1740773733_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

A Look Into Fidelity National Info Inc's Price Over Earnings

Over the last 6 sessions, many formerly high-flying stocks are down, massively. PLTR has lost over 31% during this period. SCMI shed almost the same. TSLA is down over 22%.
While many of these tickers may have good long-term reasons to be bullish, knowing when to take profits, when to protect the downside, and when to flip bearish is crucial.
There is no technical indicator or chart that is going to give you that information. Option dealers and market makers don't care about your support and resistance levels. They have to delta hedge regardless of whether your levels are breached.&nbsp; And any horizontal levels you pick on your chart will rarely ever depict where and when volatility will increase and the chances for your ticker to go bearish jump.
What if you could know for any ticker you trade when it becomes more vulnerable? What if you could know at what price the option dealers and market makers are going to sell as it falls, not buy? How about knowing when volatility could expand and thus kick your stop losses or take on bigger moves?
There is a way to find this exact price.
Here at Benzinga, and particularly in the Benzinga Option School, we've built a proprietary indicator that does just this. We call it the BBP level, otherwise known as the Bull/Bear Pivot level.
While I'm not going to give away the keys to the kingdom, I can tell you this proprietary indicator is based upon two key principles (and a lot of quantitative data). First, it's based upon option positioning (all of it for each ticker). Second, it estimates exactly where the option dealer and market maker hedging shifts to where the dealers will have to sell if the market goes down, not buy.
If you buy a dip and the dealers are buying, the chances of your bullish trade working out increase dramatically. But if you buy a dip and the dealers are forced to sell, they are trading against you, and you're fighting against a much larger force that will severely impact your trade.
This is exactly what the BBP level provides our Benzinga Option School members, and it can give you a massive edge on knowing when to buy that dip, or to sell. When to hedge or keep your bullish exposure. When to reduce leverage or buy downside protection.
Let me give a few examples below of the BBP level in action:
<h2 class="wp-block-heading">TSLA &amp; the BBP Level</h2>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="612" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28145128/tsla-gamma-1024x612.png" alt="" class="wp-image-804428" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28145128/tsla-gamma-1024x612.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28145128/tsla-gamma-300x179.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28145128/tsla-gamma-768x459.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28145128/tsla-gamma.png 1289w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
The chart above shows many of our proprietary quantitative levels for Tesla option positioning, particularly examining a primary variable for the open interest.
You'll see pink bars on the left (puts) and blue bars on the right (calls).
On the top left, you'll see an orange flag which says "Pivot" on it. That is our BBP level, our Bull/Bear Pivot. Here, that ‘pivot' is lined up at $400.
The basic rules of thumb when using and trading with this is as follows:
<ol>
<li>When the stock trades below the BBP level, we take profits on our bullish positions + do not add any new bullish positions</li>
<li>If we get deeper into the pink territory (all depends upon the structure of the pink bars), we then consider hedging any long stock positions we want to keep.</li>
<li>If certain ‘changes' happen in our structure or levels, then we'll look for outright bearish positions.</li>
</ol>
If you look at the following chart below for Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), you can see that once we had our impulsive break and close below $400, it's been (for the most part) a one-way train, losing over 29% since and only weak/corrective bounces.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="502" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28145156/TSLA_2025-02-27_14-26-26-1024x502.png" alt="" class="wp-image-804430" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28145156/TSLA_2025-02-27_14-26-26-1024x502.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28145156/TSLA_2025-02-27_14-26-26-300x147.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28145156/TSLA_2025-02-27_14-26-26-768x377.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28145156/TSLA_2025-02-27_14-26-26-1536x753.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28145156/TSLA_2025-02-27_14-26-26.png 1835w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
TSLA 1hr chart
Now I'd like you to think about what it would be like to have a level, that if you break below, you either a) trim your bullish positions, b) maybe sell some calls to lower your cost basis, c) start to hedge and protect your downside, or d) shift to outright bearish mode and make money as the stock goes down?
What would that do for your trading to have these levels every day?
How much money would it save you holding onto losing positions?
What would it do for your confidence to ‘know' when to start shifting from bullish to bearish with clarity?
By the way, let me let you in on a few other BBP levels:
<ul>
<li>On February 19, our BBP level for Palantir (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) was $115, and it closed at $112 on that day. Since then, it's lost 24%.</li>
<li>On February 25, Super Micro Computer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) had its BBP level at $53. The next day, it fell below our BBP level and has dropped 15% since.</li>
<li>NVDA had its BBP level at $130, as I'm writing this, which I  warned our Benzinga Option School members about ahead of time, saying:</li>
</ul>
"If NVDA can recapture 140, this means calls are completely in control, so should find more supportive flows above there. Meanwhile losing 130 would bring puts more into control, and thus a more vulnerable position for NVDA."
I told our members before the market opened that if NVDA fell below the 130 level (the BBP level), it would be vulnerable to losses as dealers would start selling as it fell.
NVDA closed today at $10 lower and $120.31.&nbsp;
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="502" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28145217/NVDA_2025-02-27_14-41-59-1024x502.png" alt="" class="wp-image-804431" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28145217/NVDA_2025-02-27_14-41-59-1024x502.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28145217/NVDA_2025-02-27_14-41-59-300x147.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28145217/NVDA_2025-02-27_14-41-59-768x377.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28145217/NVDA_2025-02-27_14-41-59-1536x753.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28145217/NVDA_2025-02-27_14-41-59.png 1835w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
NVDA 5min chart
Our members were prepared ahead of time to reduce bullish positions and start looking for bearish plays.
Had you known about this today, you likely would have saved yourself a ton of money. Now imagine that but having the knowledge and level every day you trade. What would that do for your trading? How many big losses would be smaller? How many times would you be able to profit from a shift in bearish positioning?
That is the power of the BBP level.
If you'd like to learn more about the BBP level, or see me use trading live, you can become a member of the <a href="https://www.benzinga.com/premium/ideas/benzinga-options-school-webinar/?el=ResearchDaily&amp;he={{email}}&amp;adt_ei={{email}}&amp;utm_adType=SponsorAd&amp;utm_ad=RD0301&amp;utm_campaign=optionsschool">Benzinga Option School.</a>
I look forward to working with you and teaching you how to use this BBP level for your trading.
Image via MidJourney AI

Opinion

PLTR

SMCI

How I Saw This Tech Crash Coming a Mile Away – And You Could Have Too

CARS

Cars.Com shares are trading higher, reversing after falling Thursday on worse-than-expected Q4 financial results.

In the latest quarter, 11 analysts provided ratings for Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>), showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">7</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Aflac, revealing an average target of $103.64, a high estimate of $118.00, and a low estimate of $94.00. Surpassing the previous average price target of $103.00, the current average has increased by 0.62%.
<img src="https://www.benzinga.com/files/images/story/2025/1740772856_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Aflac. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nigel Dally</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$105.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$102.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>Ryan Krueger</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$104.00</td>
<td>$107.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$95.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>John Barnidge</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$118.00</td>
<td>$122.00</td>
</tr>
<tr>
<td>Jack Matten</td>
<td>BMO Capital</td>
<td>Announces</td>
<td>Market Perform</td>
<td>$111.00</td>
<td>-</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$104.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>Ryan Krueger</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$107.00</td>
<td>$108.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$94.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$98.00</td>
<td>$96.00</td>
</tr>
<tr>
<td>Thomas Gallagher</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$102.00</td>
<td>$104.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Aflac. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Aflac compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Aflac's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Aflac's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AFL/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Aflac analyst ratings.</a>
<h2>Discovering Aflac: A Closer Look</h2>
Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.
<h3>Aflac: A Financial Overview</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Aflac's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 44.53%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Aflac's net margin excels beyond industry benchmarks, reaching 34.59%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 7.47%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.55%, the company showcases effective utilization of assets.
Debt Management: Aflac's debt-to-equity ratio is below the industry average at 0.29, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

11 Analysts Have This To Say About Aflac

In the latest quarter, 8 analysts provided ratings for Lincoln National (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNC#NYSE">LNC</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $37.88, a high estimate of $44.00, and a low estimate of $28.00. This upward trend is evident, with the current average reflecting a 6.7% increase from the previous average price target of $35.50.
<img src="https://www.benzinga.com/files/images/story/2025/1740772849_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Lincoln National among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nigel Dally</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$42.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Thomas Gallagher</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$44.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$36.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Nigel Dally</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$39.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Ryan Krueger</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$40.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$38.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$28.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$36.00</td>
<td>$38.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Lincoln National. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Lincoln National compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Lincoln National's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
To gain a panoramic view of Lincoln National's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/LNC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Lincoln National analyst ratings.</a>
<h2>Unveiling the Story Behind Lincoln National</h2>
Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability and dental.
<h3>Understanding the Numbers: Lincoln National's Finances</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Lincoln National's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 605.13%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Lincoln National's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 32.91%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Lincoln National's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 21.86%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Lincoln National's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.42% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Lincoln National's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.87, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On Lincoln National Through 8 Analysts

Deep-pocketed investors have adopted a bullish approach towards Intuitive Machines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in LUNR usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 18 extraordinary options activities for Intuitive Machines. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 44% leaning bullish and 38% bearish. Among these notable options, 5 are puts, totaling $330,540, and 13 are calls, amounting to $4,304,059.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $10.5 to $19.0 for Intuitive Machines over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Intuitive Machines's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Intuitive Machines's substantial trades, within a strike price spectrum from $10.5 to $19.0 over the preceding 30 days.
<h3>Intuitive Machines 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740772847_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LUNR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$3.55</td>
<td>$3.5</td>
<td>$3.55</td>
<td>$12.00</td>
<td>$1.8M</td>
<td>2.0K</td>
<td>7.9K</td>
</tr>
<tr>
<td>LUNR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$3.5</td>
<td>$3.45</td>
<td>$3.45</td>
<td>$12.00</td>
<td>$764.3K</td>
<td>2.0K</td>
<td>13.5K</td>
</tr>
<tr>
<td>LUNR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$3.6</td>
<td>$3.55</td>
<td>$3.6</td>
<td>$12.00</td>
<td>$679.5K</td>
<td>2.0K</td>
<td>15.6K</td>
</tr>
<tr>
<td>LUNR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$3.45</td>
<td>$3.0</td>
<td>$3.35</td>
<td>$12.00</td>
<td>$477.8K</td>
<td>2.0K</td>
<td>61</td>
</tr>
<tr>
<td>LUNR</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/28/25</td>
<td>$5.1</td>
<td>$4.9</td>
<td>$5.0</td>
<td>$19.00</td>
<td>$100.0K</td>
<td>1.1K</td>
<td>205</td>
</tr>
</tbody>
</table>

<h3>About Intuitive Machines</h3>
Intuitive Machines Inc is a space exploration, infrastructure, and services company. It is a diversified space company focused on space exploration. It supplies space products and services to support sustained robotic and human exploration to the Moon, Mars, and beyond. Its products and services are offered through its four business units: Lunar Access Services, Orbital Services, Lunar Data Services, and Space Products and Infrastructure.
<h3>Current Position of Intuitive Machines</h3>
<ul>
<li>Trading volume stands at 13,228,001, with LUNR's price up by 2.4%, positioned at $14.74.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 20 days.</li>
</ul>
<h3>What The Experts Say On Intuitive Machines</h3>
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $16.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from B of A Securities downgraded its action to Underperform with a price target of $16. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Intuitive Machines options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

LUNR

Decoding Intuitive Machines's Options Activity: What's the Big Picture?

Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) has outperformed the market over the past 5 years by 17.19% on an annualized basis producing an average annual return of 31.55%. Currently, Fluor has a market capitalization of $6.43 billion. 
Buying $1000 In FLR: If an investor had bought $1000 of FLR stock 5 years ago, it would be worth $3,794.82 today based on a price of $38.10 for FLR at the time of writing.
<h3>Fluor's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740772846_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Fluor 5 Years Ago Would Be Worth Today

Ratings for Iovance Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $16.38, a high estimate of $32.00, and a low estimate of $6.00. Highlighting a 10.88% decrease, the current average has fallen from the previous average price target of $18.38. 
<img src="https://www.benzinga.com/files/images/story/2025/1740772842_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The analysis of recent analyst actions sheds light on the perception of Iovance Biotherapeutics by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Ulz</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$20.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Joseph Catanzaro</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$6.00</td>
<td>$7.50</td>
</tr>
<tr>
<td>Joseph Pantginis</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$32.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Joseph Catanzaro</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$7.50</td>
<td>$10.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Iovance Biotherapeutics. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Iovance Biotherapeutics compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Iovance Biotherapeutics's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Iovance Biotherapeutics's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/IOVA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Iovance Biotherapeutics analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Delving into Iovance Biotherapeutics's Background</h2>
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
<h3>Financial Insights: Iovance Biotherapeutics</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Positive Revenue Trend: Examining Iovance Biotherapeutics's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 12384.86% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -142.67%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Iovance Biotherapeutics's ROE excels beyond industry benchmarks, reaching -10.84%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Iovance Biotherapeutics's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -8.54%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Iovance Biotherapeutics's debt-to-equity ratio is below the industry average at 0.1, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

General Copper Gold

General Copper Gold (GNRGF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga